9EPANOSTIKA(Tm) Anti-Hav Igm
PMA P830017
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA PMAAPPR | NumberP830017 | Date21 Mar 1990 | StatusActive |
Recalls
No FDA recalls found in the data synced 6 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA PMA Active
Specification
- Generic Name
- Hepatitis a test (antibody and igm antibody)
- PMA Number
- FDA Product Code
- LOL
- Device Class
- Class II
- Regulation
- 21 CFR Part 866.3310
- Advisory Committee
- Microbiology
- FDA Decision
- APPR Approved
- PMA Supplement
- S001 (Normal 180 Day Track)
Overview
AI-generated summary, 18 Sep 2026
The 9Epanostika Anti-HAV IgM is an in vitro diagnostic device classified as a Hepatitis A Test (Antibody and IgM Antibody). It is designed to detect IgM antibodies to Hepatitis A virus (HAV) in human serum or plasma, aiding in the diagnosis of acute Hepatitis A infection.
This device is intended for use in clinical microbiology laboratories. Supplied as a single-use reagent kit, it requires no sterilisation beyond its original packaging. The test is regulated under FDA Premarket Approval (PMA) with PMA number P830017 and falls under regulation number 866.3310. Storage and handling follow standard in vitro diagnostic procedures as specified in the accompanying instructions.
Other devices from Organon Teknika Corp.
Questions
AI-generated answers, 18 Sep 2026
What clinical purpose does the 9Epanostika Anti-HAV IgM test serve in diagnosing Hepatitis A infections?
The 9Epanostika Anti-HAV IgM test detects IgM antibodies to the Hepatitis A virus (HAV) in human serum or plasma, helping clinicians identify acute Hepatitis A infections. IgM antibodies appear early during infection, making this test useful for confirming recent or active cases.
Is this test kit designed for single-use, or can it be reused after opening?
The 9Epanostika Anti-HAV IgM is supplied as a single-use reagent kit. It does not require sterilization beyond its original packaging, and the manufacturer does not recommend reuse after opening to maintain accuracy and prevent contamination.
How is this device regulated, and what does that mean for laboratories using it?
The 9Epanostika Anti-HAV IgM is regulated under the FDA’s Premarket Approval (PMA) pathway with PMA number P830017 and falls under regulation 866.3310. This means it has undergone rigorous review by the FDA to ensure safety, effectiveness, and proper labeling before clinical use. Laboratories must follow the included instructions for storage, handling, and testing to comply with regulatory requirements.
What storage and handling precautions should be taken with this test kit?
While specific storage details are outlined in the accompanying instructions, standard in vitro diagnostic procedures apply. The kit should be stored as directed to preserve its integrity, typically in a clean, dry environment away from extreme temperatures or direct light. Always refer to the manufacturer’s guidelines for exact conditions.